Article
Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity.
Endocrinology - 1 May 2002
Tomlinson Elizabeth, Fu Ling, John Linu, Hultgren Bruce, Huang Xiaojian, Renz Mark, Stephan Jean Philippe, Tsai Saio Ping, Powell-Braxton Lyn, French Dorothy, Stewart Timothy A
Abstract excerpt
The fibroblast growth factors (FGFs), and the corresponding receptors, are implicated in more than just the regulation of epithelial cell proliferation and differentiation. Specifically, FGF23 is a regulator of serum inorganic phosphate levels, and mice deficient in FGF receptor-4 have altered cholesterol metabolism. The recently described FGF19 is unusual in that it is nonmitogenic and appears to interact only...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
